General Nuclear Medicine Track

The general nuclear medicine track features a wide-ranging scope of sessions developed and led by experts from SNMMI's specialty councils and centers of excellence. These sessions are designed to expand your knowledge on the latest clinical applications and best practices in the field advancing precision medicine.

Thursday, January 27

1:30–3:30 pm ET

Filling the Gaps in Nuclear Medicine Resident Training: Business, Simulation, Presentation, and Question-Writing Skills 
Sponsored by the SNMMI Academic Council, General Clinical Nuclear Medicine Council, Early Career Professionals Committee
Organizers: Twyla Bartel, DO, MBA, FACNM, FSNNMI; Darlene Metter, MD, FACNM, FSNMMI; Erica Cohen Major, DO, MPH, FACNM; Justin Peacock, MD, PhD
Moderators: Erica Cohen Major, DO, MPH, FACNM; Justin Peacock, MD, PhD


Session Objectives

  • Appreciate the strengths and limitations of the2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain
  • Select the appropriate cardiac noninvasive test for the patient with known or suspected CAD.
  • Discuss the role of imaging in selecting patients for coronary revascularization


Presentations include:

  • Business Knowledge and Skills Needed for Nuclear Medicine Practice
    Twyla Bartel, DO, MBA, FACNM, FSNMMI
  • Software Simulation for Enhancement of Nuclear Medicine Resident Education
    Frederick D. Grant, MD
  • How to Create an Effective PowerPoint Presentation
    Darlene Metter, MD, FACNM, FSNMMI
  • How to Write a Focused Question/Item
    Darlene Metter, MD, FACNM, FSNMMI
  • Q&A


3:45–5:45 pm ET

[18F]FDOPA:  Applications, Implementation, and the Journey to FDA Approval
Sponsored by the SNMMI Radiopharmaceutical Sciences Council
Organizers: Amy Vavere, PhD; Michael Nichols, PhD
Moderator: Amy Vavere, PhD

Session Objectives

  • Describe clinical applications for diagnosis and prognosis in oncologic and non-oncologic conditions.
  • List synthetic approaches to the preparation of FDOPA for use in patients.
  • Discuss background and details on the submission and approval process from research tracer to FDA-approved PET drug.

Presentations include:

  • Applications of FDOPA in Clinical Practice and Research
    Karel Pacak, MD, DSc, PhD
  • Review of the Synthesis and Production of [18F]FDOPA
    Michael Nickels, PhD
  • The Journey to FDA Approval of [18F]FDOPA
    Thomas C. Chaly, PhD


6:30–8:30 pm ET

Updates in Theranostics in Prostate Cancer 
Sponsored by the  SNMMI Therapy Center of Excellence
Organizers: Neeta Pandit-Taskar, MD; Ephraim E.  Parent, MD, PhD
Moderators: Ephraim E.  Parent, MD, PhD; Daniel Lee, MD

Session Objectives

  • Discuss the use of various imaging agents in prostate cancer
  • Describe the indications and use of the RPT in prostate cancer
  • Examine new developments in prostate cancer evaluation and management


Presentations include:

  • Development is Imaging Prostate Cancer
    Steven P. Rowe, MD, PhD
  • Lu-177 PSMA:  Clinical Stats
    Robert Flavell, MD, PhD
  • Prostate Theranostics:  Vision Trial and Clinical Management Perspective
    Jingsong Zhang, MD, PhD
  • Lu-177 PSMA Therapy:  Practical Aspects for Clinical Application
    Ayse Tuba-Kendi, MD
  • Panel Discussion/Q&A


Friday, January 28

8:00–10:00 am ET

Not So Common NM Studies and Their Anatomic Correlates
Sponsored by the SNMMI Correlative Imaging Council and Academic Council
Organizer: Twyla Bartel, DO, MBA, FACNM, FSNMMI

Session details TBA.

10:15 am–12:15 pm ET

The Many Potential Roles of Fibroblast Activation Protein PET
Sponsored by the SNMMI Correlative Imaging Council

Session details TBA.

1:15–3:15 pm ET

Infection/Inflammation Imaging: Where We Have Come from and the Expanding Role of FDG PET
Sponsored by the SNMMI PET Center of Excellence

Session details TBA.

3:45–5:45 pm ET

General Track Session

Session details TBA.

Saturday, January 29

8:00–10:00 am ET

Nuts and Bolts of Image Quantification and Associated AI Applications
Sponsored by the SNMMI Physics, Instrumentation and Data Sciences Council
Organizers/Moderators: R. Glenn Wells, PhD; Chi Liu, PhD

Session Objectives

  • Review the steps and corrections needed to quantify SPECT and PET images
  • Recognize potential sources of error and the levels of quantitation achievable for PET and SPECT
  • Describe how state-of-the-art artificial intelligence methods are being applied to image quantification


Presentations include:

  • Quantification of SPECT and PET
    R. Glenn Wells, PhD
  • Applying Artificial Intelligence to Image Quantification
    Chi Liu, PhD

10:30 am–12:30 pm ET

GU Made Simple
Sponsored by the SNMMI Pediatric Council/General Clinical Nuclear Medicine Council
Organizers/Moderators: Darlene Metter, MD, FACR, FACNM, FSNMMI; Lisa J. States, MD

Session Objectives

  • Describe basic renal imaging in assessing obstruction.
  • Interpret imaging in renal transplant, GU infection and GI bleeds.
  • Provide a concise VQ report in pulmonary embolism. 


Presentations include:

  • GU Made Simple – UTI 
    Eglal Shalaby-Rana, MD
  • Nucs After Dark– GI Bleed
    Lisa J. States, MD
  • GU Made Simple – Renal Transplant
    Reza Vail
  • GU Basics to Include Obstruction
    Nucs after Dark – HIDV, VQ
    Darlene Metter, MD, FACR, FACNM, FSNMMI
  • Q&A


1:30–3:30 pm ET


Amyloid Imaging: Advantages and Pitfalls to Aid Treatment of Alzheimer’s Disease
Sponsored by the SNMMI Brain Imaging Council

Session details TBA.


4:00–6:00 pm ET

Implementing Newly FDA-Approved PET/CT Imaging Agents
Sponsored by the SNMMI Clinical Trials Network and PET Center of Excellence
Organizers: Regan Butterfield, BS, CNMT ARRT(CT); Gary Ulaner, MD, PhD, FACNM
Moderators: Gary Ulaner, MD, PhD, FACNM; Steven Rowe, MD, PhD


Session Objectives

  • Review the indications and mechanisms of action of 18F-FES, 64Cu-DOTATATE, and 18F-DCFPyL.
  • Examine normal biodistribution of 18F-FES, 64Cu-DOTATATE, and 18F-DCFPyL.
  • Discuss PET/CT imaging interpretation for 18F-FES, 64Cu-DOTATATE, and 18F-DCFPyL


Presentations include:

  • 18F-Fluoroestradiol
    Gary Ulaner, MD, PhD, FACNM
  • 64Cu-DOTATATE
    Erik Mittra, MD, PhD
  • 18F-DCFPyl
    Steve Rowe, MD, PhD
  • Q&A